FIELD: medicine.
SUBSTANCE: method of hepatic fibrosis assessment in patients with chronic viral hepatitis type C consisting in evaluating CB56+ phenotype in blood lymphocytes with the value range of blood CD3+/CD56+, CD3+/CD56+/CD4+, CD3+/CD56+/CD8+, CD56+/CD94+, CD56+/NKG2D+, CD56+/CD107a+ cell percentage showing third stage (pre-cirrhotic) or cirrhosis.
EFFECT: method allows higher diagnostic accuracy in fibrous hepatic changes.
7 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2709507C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC FIBROSIS ACCOMPANYING VIRAL HEPATITIS C | 2014 |
|
RU2557927C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2724595C1 |
| METHOD FOR LABORATORY DIAGNOSIS OF STAGES OF HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIS C | 2015 |
|
RU2583939C1 |
| METHOD FOR MIXED (HCV+ALCOHOL) ETIOLOGY LIVER CIRRHOSIS FORMATION FORECASTING | 2016 |
|
RU2618418C1 |
| METHOD FOR DIAGNOSTICS OF SEVERE LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C WITH GENOTYPE 1 | 2017 |
|
RU2639480C1 |
| METHOD OF PREDICTING FAST VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2013 |
|
RU2563812C2 |
| METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1b | 2012 |
|
RU2522500C1 |
| METHOD FOR PREDICTING THE ABSENCE OF REGRESS OF HEPATIC FIBROSIS IN THE PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2723387C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
